The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature
Open accessAbstract
OBJECTIVE: The emergence of various modes of administration for cancer treatment, including oral administration, brings into focus the importance of patient preference for administration. The purpose of this research was to evaluate the administration preferences of cancer patients, specifically between oral and intravenous (IV) treatment, as well as the factors contributing to preference. METHODS: A literature search was conducted in OvidSP to identify research in which the preferences of cancer patients for oral or IV treatment have been evaluated. Data were analyzed in two stages: 1) those articles that directly compared preference between modes of administration were tallied to determine explicit preference for oral or IV treatment; and 2) all attributes associated with patient preference were documented. RESULTS: Of the 48 abstracts identified as part of the initial OvidSP search, eight articles were selected for full-text review. One article was removed following full-text review, and seven additional articles were identified through a gray literature search, yielding a total of 14 articles for evaluation. In Stage 1, 13 of the 14 articles compared preference, of which eleven articles (84.6%) reported that patients preferred oral treatment over IV, while two (15.4%) stated that cancer patients preferred IV treatment over oral. In Stage 2, the most frequently reported attributes contributing to preference included convenience, ability to receive treatment at home, treatment schedule, and side effects. DISCUSSION: Evidence suggests that oncology patients prefer oral treatment to IV. Rationale for preference was due to a number of factors, including convenience, perception of efficacy, and past experience. Further evaluation should be conducted, given the limited data on patient preference in oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Using thematic analysis in psychology
Braun, V., & Clarke, V. (2006) · Qualitative Research in Psychology · doi:10.1191/1478088706qp063oa · Cited by 194,414
Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C. L., Meier, W., Shapira-Frommer, R., Safra, T., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70228-1 · Cited by 1,442
Patient preferences for oral versus intravenous palliative chemotherapy.
Liu, G., Franssen, E., Fitch, M. I., & Warner, E. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.110 · Cited by 919
Adherence to Therapy With Oral Antineoplastic Agents
Partridge, A. H. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.9.652 · Cited by 584
NCCN Task Force Report: Oral Chemotherapy
Weingart, S. N., Brown, E., Bach, P. B., Eng, K., Johnson, S. A., Kuzel, T. M., Langbaum, T. S., Leedy, R. D., Muller, R. J., Newcomer, L. N., et al. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.2003 · Cited by 435
Borner, M. M., Schöffski, P., de Wit, R., Caponigro, F., Comella, G., Sulkes, A., Greim, G., Peters, G. J., van der Born, K., Wanders, J., et al. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00371-9 · Cited by 316
Rowland, J. H., Kent, E. E., Forsythe, L. P., Loge, J. H., Hjorth, L., Glaser, A., Mattioli, V., & Fosså, S. D. (2013) · Cancer · doi:10.1002/cncr.28060 · Cited by 133
Towards a Prague Definition of Grey Literature
Schöpfel, J., & GreyNet International, G. L. N. S. (2011) · HAL · doi:10.17026/dans-xdx-88ux · Cited by 123
Noble, S., Nelson, A., & Seaman, S. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s58595 · Cited by 91
Use of Conjoint Analysis to Assess Breast Cancer Patient Preferences for Chemotherapy Side Effects
Beusterien, K. M., Grinspan, J., Kuchuk, I., Mazzarello, S., Dent, S. F., Gertler, S. Z., Bouganim, N., Vandermeer, L., & Clemons, M. J. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0359 · Cited by 84
Pfeiffer, P., Mortensen, J. P., Bjerregaard, B., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.06.027 · Cited by 83
Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer.
DiBonaventura, M., Copher, R. M., Basurto, E., Faria, C., & Lorenzo, R. (2014) · PubMed Central · Cited by 71
Acceptance of oral chemotherapy in breast cancer patients - a survey study
Schott, S., Schneeweiß, A., Reinhardt, J., Bruckner, T. M., Domschke, C., Sohn, C., & Eichbaum, M. H. R. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-129 · Cited by 51
Zagadailov, E. A., Fine, M. J., & Shields, A. L. (2013) · PubMed Central · Cited by 51
Self-citationOpinions of French patients with schizophrenia regarding injectable medication
Caroli, Raymondet, P., Izard, Plas, Gall, B., & Delgado, L. (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s15337 · Cited by 36
A quantitative assessment of patient barriers to insulin
Casciano, R., Malangone, E., Ramachandran, A., & Gagliardino, J. J. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02590.x · Cited by 35
Teuffel, O., Cheng, S. S., Ethier, M. C., Diorio, C. J., Martino, J. G., Mayo, C., Wing, R., Sung, L., & Alibhai, S. M. H. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1397-8 · Cited by 30
Maintenance Therapy for Advanced Non–Small-Cell Lung Cancer: A Pilot Study on Patients’ Perceptions
Peeters, L., Sibille, A., Anrys, B., Oyen, C., Dooms, C., Nackaerts, K., Wauters, I., & Vansteenkiste, J. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31825879ea · Cited by 27
The preferences and experiences of different bisphosphonate treatments in women with breast cancer
Fallowfield, L. J., Stebbing, J., Braybrooke, J. P., Langridge, C., & Jenkins, V. A. (2010) · Psycho-Oncology · doi:10.1002/pon.1781 · Cited by 12
Cited by
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 492
An Overview of PARP Inhibitors for the Treatment of Breast Cancer
Cortesi, L., Rugo, H. S., & Jackisch, C. (2021) · Targeted Oncology · doi:10.1007/s11523-021-00796-4 · Cited by 393
Zero-order drug delivery: State of the art and future prospects
Laracuente, M.-L., Yu, M. H., & McHugh, K. J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.020 · Cited by 384
Aguiar-Ibáñez, R., Fotheringham, I., Mittal, L., Sillah, A., & Pathak, S. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02985-9 · Cited by 19
Grossi, F., Jaśkiewicz, P., Ferreira, M., Czyżewicz, G., Kowalski, D., Ciuffreda, L., Garcia-Gomez, R., Caruso, S., Bosch-Barrera, J., Gautier, S., et al. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211022905 · Cited by 5
Metadata
- Authors
- Krohe, M., Eek, D., Mazar, I., Horsfield, A., Pompilus, F., Friebe, R., & Shields, A.
- Venue
- Patient Preference and Adherence
- Publisher
- Informa UK Limited
- Published
- 2016-08
- Volume
- Volume 10
- Pages
- 1609-1621
- ISSN
- 1177-889X (ISSN-L)
- OpenAlex
- W2509578420
- Cited by
- 265
- References
- 19
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.